News
News
- Bellicum Announces Interim BPX-601 Data and Corporate Restructuring
10/29/2020 / 22:15 - GlobeNewswire - INmune Bio, Inc. to Report Third Quarter 2020 Financial Results and Provide a Corporate Update on Thursday, November 5
10/29/2020 / 13:30 - GlobeNewswire - Cellect Biotechnology Commences Collaboration with XNK Therapeutics to Advance Novel NK Cell-Based Therapies; Adds Another Partner for its Functional Cell Selection Technology
10/29/2020 / 13:00 - GlobeNewswire - Equinor ASA: Information relating to dividend for third quarter 2020
10/29/2020 / 06:45 - GlobeNewswire - Equinor third quarter 2020 results
10/29/2020 / 06:43 - GlobeNewswire - Rubius Therapeutics Presents Preclinical Data for RTX-321, a Red Cell Therapeutic™ Oncology Product Candidate for HPV-Positive Cancers, Demonstrating its Dual Mechanism of Action
10/28/2020 / 10:00 - GlobeNewswire - Medicenna Presents Promising Preclinical Data on IL-2 and IL-13 Superkines at the EORTC-NCI-AACR Annual Meeting
10/26/2020 / 13:00 - GlobeNewswire - Medicenna Presents Late Breaking Abstract Updating Results from Phase 2b Recurrent GBM Trial at the 36th EORTC-NCI-AACR Meeting
10/26/2020 / 12:00 - GlobeNewswire - Kiadis announces presentation at the 2020 Society for Immunotherapy of Cancer Annual Meeting
10/26/2020 / 07:00 - GlobeNewswire - First Patient Dosed in Monalizumab Phase 3 Clinical Trial Triggers $50M Payment From AstraZeneca
10/23/2020 / 07:00 - GlobeNewswire
Real-time